Splenectomy and chronic thromboembolic pulmonary hypertension

X Jaïs, V Ioos, C Jardim, O Sitbon, F Parent, A Hamid, E Fadel, P Dartevelle, G Simonneau, M Humbert, X Jaïs, V Ioos, C Jardim, O Sitbon, F Parent, A Hamid, E Fadel, P Dartevelle, G Simonneau, M Humbert

Abstract

Background: An increased prevalence of splenectomy has been reported in patients with idiopathic pulmonary arterial hypertension. Examination of small pulmonary arteries from these subjects has revealed multiple thrombotic lesions, suggesting that thrombosis may contribute to this condition. Based on these findings, we hypothesised that splenectomy could be a risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), a condition defined by the absence of thrombus resolution after acute pulmonary embolism that causes sustained obstruction of the pulmonary arteries and subsequent pulmonary hypertension.

Methods: The medical history, clinical characteristics, thrombotic risk factors and haemodynamics of 257 patients referred for CTEPH between 1989 and 1999 were reviewed. In a case-control study the prevalence of splenectomy in patients with CTEPH was compared with that of patients evaluated during the same period for idiopathic pulmonary hypertension (n=276) or for lung transplantation in other chronic pulmonary conditions (n=180).

Results: In patients with CTEPH, 8.6% (95% CI 5.2 to 12.0) had a history of splenectomy compared with 2.5% (95% CI 0.7 to 4.4) and 0.56% (95% CI 0 to 1.6) in cases of idiopathic pulmonary arterial hypertension and other chronic pulmonary conditions, respectively (p<0.01).

Conclusion: Splenectomy may be a risk factor for chronic thromboembolic pulmonary hypertension.

References

    1. Arch Intern Med. 2000 Jan 24;160(2):159-64
    1. Arch Surg. 1978 Jul;113(7):808-9
    1. Eur Respir J. 2000 Feb;15(2):395-9
    1. Dig Dis Sci. 2000 Feb;45(2):373-7
    1. Am J Hematol. 2001 Jul;67(3):197-9
    1. N Engl J Med. 2001 Nov 15;345(20):1465-72
    1. Br J Haematol. 2002 Sep;118(3):893-8
    1. Hemoglobin. 2003 Aug;27(3):139-47
    1. Eur Respir J. 2004 Apr;23(4):637-48
    1. Br J Haematol. 1966 Jan;12(1):44-53
    1. Australas Ann Med. 1966 May;15(2):122-8
    1. Biomed Pharmacother. 1985;39(6):264-71
    1. Am Heart J. 1987 Nov;114(5):1262-4
    1. Br J Surg. 1989 May;76(5):517-21
    1. Circulation. 1990 Jun;81(6):1735-43
    1. Chest. 1990 Nov;98(5):1067-72
    1. Circulation. 1992 Oct;86(4):1241-8
    1. Chest. 1993 Mar;103(3):685-92
    1. Circulation. 1994 Jun;89(6):2715-21
    1. Circulation. 1994 Aug;90(2):706-12
    1. Am J Med. 1995 Oct;99(4):392-6
    1. Br J Haematol. 1996 May;93(2):303-10
    1. Thromb Haemost. 1996 Sep;76(3):476-7
    1. Am J Hematol. 1998 Jan;57(1):82-4
    1. Blood. 1998 Apr 15;91(8):3044-51
    1. Mayo Clin Proc. 1998 Sep;73(9):873-9
    1. Ann Intern Med. 1999 Mar 16;130(6):506-9
    1. Aust N Z J Surg. 1976 Feb;46(1):32-6

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit